Skip to main content
Log in

Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) is a well-established rating instrument to assess the functional status of ALS patients. A recent innovation was the addition of three further items designed to improve its sensitivity at lower levels of physical function (ALSFRS-Extension, ALSFRS-EX). Neither the ALSFRS-R nor the ALSFRS-EX has been validated in German yet. The aim of the present study was the validation of the German version of a self-administered form of the ALSFRS-EX. Seventy-six patients participated in the study. Psychometric analysis included reliability assessment and factorial analysis. To evaluate convergent validity, correlations between ALSFRS-EX items and the MRC score, spasticity, tongue movement, pulmonary function, ALSAQ-40 and Borg dyspnoea scales (upright and supine) were performed. Internal consistency as measured by Cronbach’s alpha (total scale 0.868, subscales 0.690–0.938) and corrected item to total correlations (all above 0.50) was high. Test–retest reliability assessed by Spearman’s rho (0.882–0.972) and Cohen’s Kappa (0.63–0.92) was also high. Principal component analysis with varimax rotation yielded a four-factor solution accounting for approximately 79 % of the variance. Clinical parameters were strongly correlated with respective items and subscores of the ALSFRS-EX (muscle strength 0.568–0.833 p < 0.01; spasticity −0.236 to −0.376 p < 0.05; tongue movement 0.437–0.818 p < 0.01; pulmonary function 0.485–0.577 p < 0.01). ALSAQ-40 and Borg score correlated highly with the corresponding ALSFRS-EX items. The German self-report version of the ALSFRS-EX possesses very good psychometric properties similar to the original scale including high internal consistency and test–retest reliability as well as excellent convergent validity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates the assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21

    Article  PubMed  CAS  Google Scholar 

  2. Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, Mitsumoto H (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:1294–1296

    Article  PubMed  CAS  Google Scholar 

  3. Cedarbaum JM, Stambler N (1997) Performance of the Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS) in multicenter trials. J Neurol Sci 152(Suppl 1):S1–S9

    Article  PubMed  Google Scholar 

  4. Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, Sumino S, Yanagisawa N (2001) Study of functional rating scale for amytrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346–355

    PubMed  CAS  Google Scholar 

  5. Kim HY, Park KH, Koh SH, Lee SC, Nam YH, Kim J, Kim SH (2007) Korean version of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised: a pilot study on the reliability and validity. J Korean Neurol Assoc 25:149–154

    Google Scholar 

  6. Guedes K, Pereira C, Pavan K, Valério BC (2010) Cross-cultural adaptation and validation of ALS functional rating scale-revised in Portuguese language. Arq Neuropsiquiatr 68:44–47

    Article  PubMed  Google Scholar 

  7. Campos TS, Rodríguez-Santos F, Esteban J, Vázquez PC, Mora Paradina JS, Carmona AC (2010) Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS-R). Amyotroph Lateral Scler 11:475–477

    Article  PubMed  Google Scholar 

  8. Atsuta N, Watanabe H, Ito M, Nakamura R, Senda J, Kato S, Sobue G (2011) Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study. Brain Nerve 63:491–496

    PubMed  Google Scholar 

  9. Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, Battista V, Arbing R, Gordon PH, Mitsumoto H, Levin B, Thompson JL, QALS study group (2007) Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter trial. Amyotroph Lateral Scler 8:42–46

    Article  PubMed  Google Scholar 

  10. Kasarskis EJ, Dempsey Hall L, Thompson MM, Luu LC, Mendiondo M, Kryscio R (2005) Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 6:50–54

    Article  PubMed  Google Scholar 

  11. Miano B, Stoddard GJ, Davis S, Bromberg MB (2004) Inter-evaluator reliability of the ALS functional rating scale. Amyotroph Lateral Scler Other Motor Neuron Disord 5:235–239

    Article  PubMed  Google Scholar 

  12. Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V (2007) Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 14:79–84

    Article  PubMed  CAS  Google Scholar 

  13. Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C, Meyer R, Meyer T (2012) Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler 13:210–216

    Article  PubMed  Google Scholar 

  14. Wicks P, Massagli MP, Wolf C, Heywood J (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol 16:353–359

    Article  PubMed  CAS  Google Scholar 

  15. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disorder 1:293–299

    Article  CAS  Google Scholar 

  16. Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847–852

    Article  PubMed  Google Scholar 

  17. Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, Al-Chalabi A (2011) Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:853–854

    Article  PubMed  CAS  Google Scholar 

  18. Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206–207

    PubMed  CAS  Google Scholar 

  19. Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M (1999) Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 246 Suppl 3:III16-21

    Google Scholar 

  20. Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T (2010) The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J 35:353–360

    Article  PubMed  CAS  Google Scholar 

  21. Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale

    Google Scholar 

  22. Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN (1999) Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53:1051–1058

    Article  PubMed  CAS  Google Scholar 

  23. Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, Oxford

    Google Scholar 

  24. Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A (2013) Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry Epub ahead of print 2013 doi:10.1136/jnnp-2012-304701

  25. Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ (2008) ALSFRS and Appel ALS scores: discordance with disease progression. Muscle Nerve 37:668–672

    Article  PubMed  Google Scholar 

  26. Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 11:707–719

    Article  Google Scholar 

  27. Shoesmith CL, Findlater K, Rowe A (2007) Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629–631

    Article  PubMed  Google Scholar 

  28. Tanaka Y, Yoshikura N, Harada N, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Inuzuka T (2012) Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis. Intern Med 51:579–584

    Article  PubMed  CAS  Google Scholar 

  29. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  PubMed  CAS  Google Scholar 

  30. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601–609

    Article  PubMed  CAS  Google Scholar 

  31. Menke RA, Abraham I, Thiel CS, Filippini N, Knight S, Talbot K, Turner MR (2012) Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 69:1493–1499

    Article  PubMed  Google Scholar 

  32. Iwata NK, Kwan JY, Danielian LE, Butman JA, Tovar-Moll F, Bayat E, Floeter MK (2011) White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134:2642–2655

    Article  PubMed  Google Scholar 

  33. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR (2010) Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75:1645–1652

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to express their gratitude to the patients who participated in this study. This work was supported by the Stiftung für Medizinische Wissenschaft, Frankfurt am Main (to SV) and by the excellence program of the state of Saxony-Anhalt (to HJH).

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards

The study was approved by the institutional ethics committees of Hannover Medical School and the University of Magdeburg and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanne Abdulla.

Appendix

Appendix

Der ALSFRS-EX ist eine Bewertungsskala und wird verwendet, um die aktuellen Beeinträchtigungen von alltäglichen Fähigkeiten und körperlichen Funktionen bei Patienten mit ALS festzustellen.

Es werden 15 Bereiche betrachtet. Zu jedem Bereich gibt es 5 Auswahlmöglichkeiten (von 0 bis 4) um einzuschätzen, ob eine Beeinträchtigung vorliegt und wie stark diese ausgeprägt ist. Die rechte Spalte erläutert die jeweilige Aussage genauer und mit Beispielen und soll Ihnen helfen die zutreffende Aussage auszuwählen.

Lesen Sie bitte jeden Bereich und die dazugehörigen 5 Aussagen genau durch. Bitte wählen Sie die Aussage aus, welche Ihre aktuelle Situation zutreffend beschreibt und markieren Sie diese Aussage mit einem Kreuz in dem daneben stehenden Kreis.

Sollten Sie Schwierigkeiten beim Ausfüllen der Bewertungsskala haben, lassen Sie sich bitte dabei helfen.

Die Beantwortung ist freiwillig. Ihre Angaben werden streng vertraulich behandelt.

Vielen Dank fürs Mitmachen!

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdulla, S., Vielhaber, S., Körner, S. et al. Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure. J Neurol 260, 2242–2255 (2013). https://doi.org/10.1007/s00415-013-6955-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6955-6

Keywords

Navigation